Smart insulin pens and quality of life in diabetes
Part of Hormones & metabolism clinical trials.
This study tests if smart insulin pens that connect to continuous glucose monitors can improve quality of life for people with diabetes who need help managing their treatment. If you use multiple daily injections, a glucose sensor, and rely on a healthcare provider, this trial may help find better ways to manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have type 1 or type 2 diabetes.
- You use multiple daily insulin injections.
- You already use a continuous glucose monitor and a smart insulin pen for at least one month.
- You depend on a healthcare provider (like a nurse or doctor) to help manage your diabetes.
- You agree to participate and allow your data to be collected.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if combining lifestyle coaching with a continuous glucose monitor (CGM) helps people with type 2 diabetes improve their blood sugar control. You'll track your glucose levels using a study device and see how daily habits affect them.
This trial tests a smart insulin pen that connects with a continuous glucose monitor to help you manage your blood sugar. It may offer coaching tips to improve your insulin dosing.
This trial is testing whether a telemedicine program combined with smart insulin pens can help improve blood sugar control. It is for people with diabetes who use multiple daily insulin injections and have a smartphone.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests whether using a continuous glucose monitor (FreeStyle Libre 2) along with smart insulin pens or caps helps people with type 1 diabetes better manage their blood sugar on their own. If you already use this device and take multiple daily insulin injections, you may be eligible.
This trial tests a smart phone-based system that helps doctors monitor diabetes and adjust insulin treatment. It could make blood sugar control easier for people with type 2 diabetes.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.